Literature DB >> 27852582

Association between OCT-based microangiography perfusion indices and diabetic retinopathy severity.

Alexander D Lin1, Aaron Y Lee1, Qinqin Zhang2, Kasra A Rezaei1, James Kinyoun1, Ruikang K Wang1,2, Cecilia S Lee1.   

Abstract

AIM: To evaluate the association between retinal capillary non-perfusion and diabetic retinopathy (DR) severity using optical coherence tomography-based microangiography (OMAG).
METHODS: 33 patients (51 eyes) with a history of diabetes underwent imaging with a 68 kHz Cirrus-5000 spectral domain OMAG prototype. Demographic and clinical characteristics were collected. The perfusion index (PI) was defined as per cent coverage of area by retinal vessels with flow, measured within a minimum of 6.8×6.8 mm2 OMAG scan. The PI in each ETDRS zone was analysed using an automated algorithm. Univariate and multivariate analyses were used to determine the degree of association between PI and DR severity.
RESULTS: 51 eyes with different DR severities were imaged. More severe DR was significantly associated with lower PI after adjusting for logarithm of the minimum angle of resolution best-corrected visual acuity, hyperlipidaemia, diabetes type and ETDRS ring in a multivariate mixed linear model. Compared with the none-mild non-proliferative diabetic retinopathy (NPDR) group, the moderate-severe NPDR group had 2.7 lower PI (p=0.03) and proliferative DR group had 4.3 lower PI (p=0.003). All ETDRS zones except for the foveal centre showed inverse associations between PI and DR severity (p values<0.001 to 0.862).
CONCLUSIONS: A statistically significant inverse association exists between PI and DR severity. Our study suggests that PI may become a useful biomarker in evaluating and following the progression of DR. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

Entities:  

Keywords:  Diagnostic tests/Investigation; Imaging; Retina

Mesh:

Year:  2016        PMID: 27852582      PMCID: PMC5536958          DOI: 10.1136/bjophthalmol-2016-309514

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  24 in total

1.  Correlation of histologic and clinical images to determine the diagnostic value of fluorescein angiography for studying retinal capillary detail.

Authors:  Kanishka R Mendis; Chandrakumar Balaratnasingam; Paula Yu; Chris J Barry; Ian L McAllister; Stephen J Cringle; Dao-Yi Yu
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-05-26       Impact factor: 4.799

2.  Three dimensional optical angiography.

Authors:  Ruikang K Wang; Steven L Jacques; Zhenhe Ma; Sawan Hurst; Stephen R Hanson; Andras Gruber
Journal:  Opt Express       Date:  2007-04-02       Impact factor: 3.894

3.  Megahertz OCT for ultrawide-field retinal imaging with a 1050 nm Fourier domain mode-locked laser.

Authors:  Thomas Klein; Wolfgang Wieser; Christoph M Eigenwillig; Benjamin R Biedermann; Robert Huber
Journal:  Opt Express       Date:  2011-02-14       Impact factor: 3.894

4.  Optical Coherence Tomography Angiography in Diabetic Retinopathy: A Prospective Pilot Study.

Authors:  Akihiro Ishibazawa; Taiji Nagaoka; Atsushi Takahashi; Tsuneaki Omae; Tomofumi Tani; Kenji Sogawa; Harumasa Yokota; Akitoshi Yoshida
Journal:  Am J Ophthalmol       Date:  2015-04-18       Impact factor: 5.258

Review 5.  Role of blood flow and impaired autoregulation in the pathogenesis of diabetic retinopathy.

Authors:  E M Kohner; V Patel; S M Rassam
Journal:  Diabetes       Date:  1995-06       Impact factor: 9.461

6.  Grading diabetic retinopathy from stereoscopic color fundus photographs--an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group.

Authors: 
Journal:  Ophthalmology       Date:  1991-05       Impact factor: 12.079

7.  Optical Microangiography: A Label Free 3D Imaging Technology to Visualize and Quantify Blood Circulations within Tissue Beds in vivo.

Authors:  Ruikang K Wang
Journal:  IEEE J Sel Top Quantum Electron       Date:  2010-05       Impact factor: 4.544

8.  The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes.

Authors:  R Klein; B E Klein; S E Moss; K J Cruickshanks
Journal:  Ophthalmology       Date:  1998-10       Impact factor: 12.079

9.  Frequency of adverse systemic reactions after fluorescein angiography. Results of a prospective study.

Authors:  K A Kwiterovich; M G Maguire; R P Murphy; A P Schachat; N M Bressler; S B Bressler; S L Fine
Journal:  Ophthalmology       Date:  1991-07       Impact factor: 12.079

10.  OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY FEATURES OF DIABETIC RETINOPATHY.

Authors:  Thomas S Hwang; Yali Jia; Simon S Gao; Steven T Bailey; Andreas K Lauer; Christina J Flaxel; David J Wilson; David Huang
Journal:  Retina       Date:  2015-11       Impact factor: 4.256

View more
  12 in total

1.  Ultra-Widefield Protocol Enhances Automated Classification of Diabetic Retinopathy Severity with OCT Angiography.

Authors:  FuPeng Wang; Steven S Saraf; Qinqin Zhang; Ruikang K Wang; Kasra A Rezaei
Journal:  Ophthalmol Retina       Date:  2019-11-09

Review 2.  OCT angiography and visible-light OCT in diabetic retinopathy.

Authors:  Peter L Nesper; Brian T Soetikno; Hao F Zhang; Amani A Fawzi
Journal:  Vision Res       Date:  2017-06-21       Impact factor: 1.886

3.  Clinical Manifestations of Supra-Large Range Nonperfusion Area in Diabetic Retinopathy.

Authors:  Nianting Tong; Liangyu Wang; Huimin Gong; Lin Pan; Fuxiang Yuan; Zhanyu Zhou
Journal:  Int J Clin Pract       Date:  2022-02-03       Impact factor: 3.149

4.  Diabetic retinopathy with extensively large area of capillary non-perfusion: characteristics and treatment outcomes.

Authors:  Zijing Huang; Kunliang Qiu; Jingsheng Yi; Hongjie Lin; Dezhi Zheng; Dingguo Huang; Guihua Zhang; Haoyu Chen; Jianlong Zheng; Yifan Wang; Danqi Fang; Weiqi Chen
Journal:  BMC Ophthalmol       Date:  2022-07-04       Impact factor: 2.086

Review 5.  Adaptive optics imaging of the human retina.

Authors:  Stephen A Burns; Ann E Elsner; Kaitlyn A Sapoznik; Raymond L Warner; Thomas J Gast
Journal:  Prog Retin Eye Res       Date:  2018-08-27       Impact factor: 21.198

6.  Accurate estimation of choriocapillaris flow deficits beyond normal intercapillary spacing with swept source OCT angiography.

Authors:  Qinqin Zhang; Yingying Shi; Hao Zhou; Giovanni Gregori; Zhongdi Chu; Fang Zheng; Elie H Motulsky; Luis de Sisternes; Mary Durbin; Philip J Rosenfeld; Ruikang K Wang
Journal:  Quant Imaging Med Surg       Date:  2018-08

7.  Generating retinal flow maps from structural optical coherence tomography with artificial intelligence.

Authors:  Cecilia S Lee; Ariel J Tyring; Yue Wu; Sa Xiao; Ariel S Rokem; Nicolaas P DeRuyter; Qinqin Zhang; Adnan Tufail; Ruikang K Wang; Aaron Y Lee
Journal:  Sci Rep       Date:  2019-04-05       Impact factor: 4.379

8.  Quantitative Handheld Swept-Source Optical Coherence Tomography Angiography in Awake Preterm and Full-Term Infants.

Authors:  Kanheng Zhou; Shaozhen Song; Alex Legocki; Yuxuan Cheng; Leona Ding; Kasra A Rezaei; Ruikang K Wang; Michelle T Cabrera
Journal:  Transl Vis Sci Technol       Date:  2020-12-14       Impact factor: 3.283

9.  Determinants of Quantitative Optical Coherence Tomography Angiography Metrics in Patients with Diabetes.

Authors:  Fang Yao Tang; Danny S Ng; Alexander Lam; Fiona Luk; Raymond Wong; Carmen Chan; Shaheeda Mohamed; Angie Fong; Jerry Lok; Tiffany Tso; Frank Lai; Marten Brelen; Tien Y Wong; Clement C Tham; Carol Y Cheung
Journal:  Sci Rep       Date:  2017-05-31       Impact factor: 4.379

10.  Optical Coherence Tomography Angiography Projection Artifact Removal: Impact on Capillary Density and Interaction with Diabetic Retinopathy Severity.

Authors:  Mohamed Ashraf; Konstantina Sampani; Omar Abu-Qamar; Jerry Cavallerano; Paolo S Silva; Lloyd Paul Aiello; Jennifer K Sun
Journal:  Transl Vis Sci Technol       Date:  2020-06-05       Impact factor: 3.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.